Production of Neutralizing Antibody

Area of Science:

• Biotechnology
• Immunology
• Biopharmaceutical Development

Background:

• Monoclonal antibodies (mAbs) are crucial in early-stage biologics development due to their specificity, homogeneity, and scalability.
• mAbs serve as foundational materials for engineering antibody fragments and immunomodulatory antibodies.
• Established utility of mAbs in basic rheumatoid arthritis (RA) research.

Purpose of the Study:

• To introduce the fundamental hybridoma technique for monoclonal antibody (mAb) production.
• To outline the key steps involved in the hybridoma technique, from immunization to purification.
• To highlight the application of synthetic proteoliposomes for specific membrane protein targeting.

Main Methods:

• Detailed explanation of the hybridoma technique.
• Involves animal immunization, cell fusion, and hybridoma screening.
• Utilizes synthetic proteoliposomes for enhanced immunization and screening of target membrane proteins.

Main Results:

• The hybridoma technique is presented as a feasible method for mAb production.
• Demonstrates the successful application of synthetic proteoliposomes in targeting specific membrane proteins.
• Establishes a foundational protocol for generating high-affinity mAbs.

Conclusions:

• The hybridoma technique remains a cornerstone for mAb generation in biopharmaceutical research.
• Synthetic proteoliposomes offer a valuable tool for achieving specific antibody affinities, particularly for membrane proteins.
• This chapter provides a comprehensive guide to mAb production via hybridoma technology.